DIM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sartorius Stedim Biotech SA

Watchlist Manager

Watchlist

Price: 187.4 EUR -0.85% Market Closed

Market Cap: €18.2B

	Sartorius Stedim Biotech SA PAR:DIM	FR
K	KGL Resources Ltd F:KN6	AU
K	KGL Resources Ltd XMUN:KN6	AU
H	Heidelberg Pharma AG F:HPHA	DE
T	Tudor Gold Corp OTC:TDRRF	CA
V	Vonovia SE MIL:VNA	DE
	Ringkjoebing Landbobank A/S F:CJ2	DK
A	AES Corp F:AES	US
C	Compagnie De l'odet SE SWB:49F	FR
F	Flotek Industries Inc F:F2I	US

Profitability Summary

Sartorius Stedim Biotech SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

45%

Declining Gross Margin

52% > 45%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

23% > 18%

Low Net Margin

Low 3Y Average Net Margin

10%

Declining Net Margin

20% > 9%

Exceptional Free Cash Flow Margin

12%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.